Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

A clinical monitoring scenario involving pharmacokinetics of a novel anti-psychotic product will be presented for discussion in small groups. All groups will share their considerations for actions and next steps with all participants.